Report Details:
15 Companies Covered
90 Pages
Pune, India, December , 2017/MRFR Press Release/- Market Research Future published a Half Cooked research report on “Performance Enhancing Drugs Market Research Report – Global Forecast till 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023
Performance Enhancing Drugs – Market Overview
The Performance Enhancing Drugs market is projected to reach USD 0.69 Billion by 2032 at 6.6% CAGR during the forecast period 2024-2032
Performance enhancing drugs are chemical agents designed to provide an advantage in athletic performance. Muscle enlargement, increased blood’s oxygen carrying capacity are some of the effects induced by the consumption of the performance enhancing drugs.
Growing use of the anabolic steroids by athletes, increasing use of steroids for the treatment of medical conditions such as, pain management, anaemia, and certain kinds of breast cancer besides others is expected to fuel the market growth
Now there is new horizon & huge untapped market have been identified for performance enhancing drugs, as the drugs can be use by army to create an army of ‘super soldiers. SOCOM wants to use performance-enhancing drugs to create an army of ‘super soldiers.
U.S. Special Operations Command is weighing the use of nutritional supplements or even performance-enhancing drugs to push the abilities and endurance of its forces beyond current human limits, according to a report from defence news.
While special operations forces already have access to specialized resources, like dieticians & physical therapists, SOCOM is looking to increase their ability to tolerate pain, recover from injuries, and remain physically able in challenging environments. SOCOM was exploring nutritional supplements, other substances were in consideration as well.
One goal of the research to develop what Defence news referred to as “super soldiers” would be to expand troops’ ability to operate in places not well suited for human’s high altitudes or underwater in particular
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] Performance Enhancing Drugs Market Research Report
Performance Enhancing Drugs Market – Competitive Analysis
As the market seems to be attractive, growing and profitable, at the same time market has witnessed intense rivalry among existing competitors. Many new entrants expected to enter into Performance Enhancing Drugs market. There are many big players in the Performance Enhancing Drugs market such as: Taj Pharmaceuticals Limited. (India), Balkan Pharmaceuticals. (Europe), Bayer AG (Europe), AstraZeneca (Europe), Novo Nordisk A/S (Europe), BrainAlert, LLC (U.S.), Douglas Laboratories. (U.S.), Onnit Labs, LLC. (U.S.), Eli Lilly and Company. (U.S.)
Performance Enhancing Drugs Market –
Regional Analysis
The Americas dominates the global performance enhancing drugs market owing to the presence of well developed economies with high per capita income within the region like the U.S. & Canada. This Increasing prevalence of Brest cancer will boost the market growth, as anabolic steroids can be for the treatment of certain types of breast cancer.
Europe is the second largest market for performance enhancing drug market, which is followed by Asia Pacific. Availability of funds for research and development & increasing acceptance of the performance enhancing drugs within the region likely to boost the market.
Asia Pacific is the fastest growing region for the market due to the growing awareness of the performance enhancing drugs, continuously developing economies & presence of huge opportunity in the market.
On the other hand, the Middle East & Africa owns the least share of the global performance enhancing drugs market due to presence of poor economy, especially, in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector & huge healthcare expenditure